Prakoso D, De Blasio MJ, Tate M, Kiriazis H, Donner DG, Qian H, Nash D, Deo M, Weeks KL, Parry LJ, Gregorevic P, McMullen JR, Ritchie RH (2020) Gene therapy targeting cardiac phosphoinositide 3-kinase (p110alpha) attenuates cardiac remodeling in type 2 diabetes
Skipping dose levels (e.g., jumping from 0.6 mg to 1.8 mg) should be avoided, as this significantly increases the risk of adverse events
Treatment will be deemed to have failed in these patients, and they will be further studied and treated outside the trial according to normal clinical practice
Aquat Toxicol 80:261266 Fusijawa T, Ichise-Shibuya K, Katagi T (2010) Uptake and transformation of phenol by duckweed
GREAT VALUE - you get 180 capsules in each jar.